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Abstract.  Cellular migration is an essential compo- 
nent of invasive biological processes, many of which 
have been correlated with an increase in plasminogen 
activator production. Endothelial cell migration occurs 
in vivo during repair of vascular lesions and angiogen- 
esis, and can be induced in vitro by wounding a 
confluent monolayer of cells. By combining the 
wounded monolayer model with a substrate overlay 
technique, we show that cells migrating from the edges 
of an experimental wound display an increase in 
urokinase-type plasminogen activator (uPA) activity, 
and that this activity reverts to background levels upon 
cessation of movement, when the wound has closed. 
Our results demonstrate a direct temporal relationship 
between endothelial cell migration and uPA activity, 
and suggest that induction of uPA activity is a compo- 
nent of the migratory process. 
T 
HE vascular endothelium consists of a highly ordered 
monolayer of cells which provides  a  structural  and 
functional barrier between circulating  blood and the 
surrounding tissues. In response to a variety of stimuli, nor- 
mally quiescent endothelial cells can be induced to migrate. 
In vivo, this occurs during the regeneration  of  endothelial le- 
sions in large blood vessels (Fishman et al., 1975; Schwartz 
et al., 1978; Haudenschild and Schwartz,  1979), and during 
the formation of new capillary blood vessels in the process 
of angiogenesis  (Ausprunk  and Folkman,  1977; Folkman, 
1985). In vitro, endothelial cell migration can be triggered 
by mechanically wounding a confluent monolayer of cells 
(Sholley et al., 1977; Selden and Schwartz, 1979; Goflieb and 
Spector,  1981; Ryan et al.,  1982; Madri and Stenn,  1982). 
Proteases,  and  in  particular  plasminogen  activators 
(PAs),1 have been correlated with cell migration in a variety 
of invasive biological processes (Reich,  1978; Mullins and 
RJahrlich, 1983; Saksela,  1985; Dan~ et al., 1985; Goldfarb 
and Liotta,  1986). Using the wounded monolayer model to- 
gether with a substrate overlay technique, which has the ad- 
vantage of  allowing direct visualization of  proteolysis around 
migrating cells, we demonstrate here that capillary endothe- 
lial cells migrating from the edges of  an experimental wound 
display an increase in urokinase-type PA (uPA) activity. 
Materials and Methods 
Materials 
4[~-phorbol 12-myristate 13-acetate (PMA), g-aminocaproic acid, cyclohexi- 
mide, mitomycin C, and amiloride were purchased from Sigma Chemical 
1. Abbreviations used in this paper: BME, bovine microvascular  endothelial 
cells; PA, plasminogen activator;  tPA, tissue-type plasminogen activator; 
uPA, urokinase-type plasminogen activator. 
Co.  (St.  Louis,  MO).  IYasylol was  purchased from Bayer-Pharma AG 
(Zurich, Switzerland).  Affinity-purified anti-human tissue-type plasmino- 
gen activator (tPA) antibodies were a generous gift from Dr. W.-D. Schlean- 
ing (Laboratoire Central d'Hematologie,  CHUV,  Lausanne). 
BSA (Sigma Chemical Co.) was acid treated as described (Loskutoff, 
1978), to remove labile protease inhibitors. Plasminogen was purified from 
human plasma by lysine-Sepharose  (Pharmacia Fine Chemicals, Uppsala, 
Sweden) affinity chromatography (Deutsch and Mertz, 1970). 
Endothelial  Cell Culture 
Cloned microvascular  endothelial cells from bovine adrenal cortex (BME 
cells) (Furie et al., 1984), a generous gift from Drs. M. B. Furie and S. C. 
Silverstein (Columbia University,  New York), were routinely subcultured 
in gelatin-coated  tissue culture flasks (Falcon Labware, Becton-Dickinson, 
Oxnard, CA) in complete medium consisting of MEM, alpha modification 
(r  (Gibco AG, Basel, Switzerland),  supplemented with 15% heat- 
inactivated donor calf serum (Flow Laboratories, Baar, Switzerland),  peni- 
cillin (500 U/ml), and streptomycin  (100 ttg/mi).  Cells were seeded into 
35-ram gelatin-coated culture dishes (Falcon Labware),  and grown to con- 
fluence in complete medium before the experiments were started. 
Wounding  and Substrate Overlay  of 
Confluent Monolayers 
Confluent monolayers of BME cells in 35-ram culture dishes were wounded 
with a 5-ram-wide rubber policeman. Wounded cultures were washed three 
times with PBS and twice with ~t-MEM, and fresh complete medium was 
replaced.  24 h after wounding  (unless otherwise indicated),  monolayers 
were overlaid essentially as previously described (Vassalli et al.,  1977). 
Briefly, monolayers  were washed twice with PBS containing acid-treated 
BSA (1 mg/ml), and overlaid with a mixture containing 2% instant non-fat 
dry milk, 0.8% agar, and plasminogen (40 gg/ml) in r  The plates 
were incubated at 370C for 60-120 min, and photographed under dark-field 
illumination. The wound edge was photographed under phase-contrast or 
dark-field  illumination using a Zeiss ICM 405 inverted photomicroscope. 
In control experiments, plasminogen was omitted from this mixture.  In 
some experiments, Trasylol or ~-aminocaproic acid was added to the overlay 
mixture at 200 U/mi and 500 ~tg/ml, respectively. 
Cycloheximide  (0.1 Ilg/ml) was added to the culture medium 30 rain be- 
fore, and for 24 h after wounding, i.e., until the cells were overlaid.  To de- 
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24 h after wounding, with a mixture containing (a) casein and agar, 
or (b) casein, agar, and plasminogen. Under dark-field illumina- 
tion, zones of caseinolysis appear as dark bands on a white back- 
ground, revealing the production of PA by ceils lining the wound 
edge. Caseinolysis is inhibited by the addition of Trasylol (c) or 
e-aminocaproic acid (d) to overlays containing plasminogen. Over- 
lays photographed after 90 min at 37~  (Fig. 2) Wound edge ca- 
seinolysis. (a) Higher magnification of the wound edge (limits  of  the 
region of caseinolysis  indicated  by the arrows) under phase-contrast 
termine whether the effect of cycloheximide  was reversible, medium con- 
raining  the drug was removed  after 24 h, the cultures were washed,  and fresh 
complete medium was added. After a further 48 h, the cultures were over- 
laid. Control wounded  cultures that had not been treated with cyelotw.ximide 
were processed in the same way. 
Mitomycin  C (10 Ixg/ml)  was added 4 h before wounding. Wounded  cul- 
tures were incubated  in the absence of mitomycin  C for 24 h thereafter until 
being overlaid. The effect  of mitomycin  C on cell multiplication  was deter- 
mined as follows: confluent monolayers were wounded (with a blade) in 
such a way as to mark the initial wound edge (Btirk, 1973); after 24 h the 
monolayers  were fixed  and stained  by the Foulgen  technique, to facilitate  vi- 
sualization of condensed chromosomes. The  number of mitotic figures 
amongst the cells that had migrated past the initial wound edge was deter- 
mined in randomly selected  photographic  fields from treated and nontreated 
cultures. 
For the characterization of the  P~s pnxluced by wound edge cells, 
wounded monolayers  were fixed with 95 % ethanol for 2 min at room tem- 
perature,  and amiloride or affinity-purified anti-human  tPA antibodies 
added to the overlay mixture at a concentration of 1 mM or 10 gg/ml. 
respectively. 
Zyraographic Assay 
Culture media and cell lysates were prepared from PMA-stimula~l BME 
cells as previously described (Montesano  et al., 1986). Aliquots (20 gl) of 
both the culture media and the cell lysates were subjected to SDS-poly- 
acrylamide gel etectrophoresis and zymography as described (Vassalli  et 
al., 1984). Where indicated, amiloride was incorporated into the underlay 
at a concentration  of 1 mM, or afffinity-purified  anti-human tPA antibodies 
at a final concentration of 10 Ixg/ml. The zymograms were photographed 
after 8 h of incubation at T/~ 
Results 
Piasrainogen-dependent Caseinolysis 
Monolayers of BME cells were overlaid with an agar-casein 
mixture in the presence or absence of plasminogen, 24 h af- 
ter mechanical wounding.  In the presence of plasminogen, 
zones of  caseinolysis  along the edges of  the wound were mac- 
roscopically  evident as dark lines against a white background 
under dark-field illumination (Fig. 1 b). Caseinolysis did not 
occur in the absence of plasminogen (Fig. 1 a), or when the 
protease inhibitors ~-aminocaproic acid or Trasylol were in- 
cluded in the overlay mixture containing plasminogen (Fig. 
1, c and d), thus demonstrating that substrate lysis was cata- 
lyzed by plasmin. Under phase-contrast and dark-field illu- 
mination at higher magnification, the lysis was seen to be 
confined to the edge of the wounded monolayer (Fig. 2, a and 
b), and to correspond to 5-15 rows of cells from the leading 
front. 
No lysis was observed when monolayers were overlaid im- 
mediately after wounding, demonstrating that lysis was not 
due to preformed enzyme released by dead or damaged cells 
lining the wound edge (Fig. 3, a  and b). Wound-associated 
lysis was clearly evident when the cells were overlaid 24 h 
after wounding  (Fig.  3,  c  and d),  and persisted until  the 
wound  had completely closed (see  for example Fig.  5  d, 
overlaid 72  h  after  wounding).  No  lysis was observed in 
monolayers overlaid 8 d  after wounding, at which time the 
wound had been closed for a  period of 24--48 h  (Fig. 3,  e 
and f). 
microscopy. (b) Dark-field illumination  of the same region; the area 
of caseinolysis is seen as a dark band between bands of unlysed 
casein above and below (limits of the region of caseinolysis indi- 
cated by the white arrows). Bar, 500  gm. 
The Journal of Cell Biology,  Volume 105, 1987  2536 Figure 3. Time course of wound edge caseinolysis. Wounded  cultures were overlaid immediately (a, b), 24 h (c, d), and 8 d (e, f) after 
wounding. (a, c, e) The wound edge seen under phase-contrast  illumination; (b, d,f) the same fields  under dark-field  illumination. Overlays 
photographed after 120 min at 37~  Bar, 500 gm. 
Lysis did not occur when the cells had been incubated in 
the presence of cycloheximide (0.1 0g/ml), an inhibitor of 
protein synthesis (Fig. 4). This effect was completely revers- 
ible when the drug was removed and the cells overlaid after 
a further 48-h incubation in complete medium without cyclo- 
heximide (Fig. 5, a-d). 
Wounding has  been  demonstrated  to  induce  both  cell 
migration and cell division (Sholley et al., 1977; Selden and 
Schwartz, 1979; Ryan et al., 1982). Wound-edge caseinolysis 
was observed in cultures treated with mitomycin C (10 ltg/ 
ml)  (Fig.  6).  The efficacy of mitomycin C  treatment was 
confirmed by the complete absence of  mitotic figures amongst 
the migrating cells in treated cultures (Fig. 7 and Table I). 
Together these results demonstrate that the lysis is not sim- 
ply a consequence of  cell proliferation, and allow us to sepa- 
rate cell migration from cell division. Although mitomycin 
C-treated and nontreated cells had migrated approximately 
the same distance into the wound after 24 h (Fig. 7, a  and 
b), the number of cells in the wound in treated cultures was 
always less than in controls (Table I). This might account for 
the slower rate of lysis seen in mitomycin C-treated cultures 
(compare Figs. 2 and 6; although lysis is clearly evident un- 
der dark-field illumination [Figs. 2 b and 6 b], the casein- 
olysis seen by phase-contrast microscopy over mitomycin 
C-treated migrating cells [Fig. 6 a] is not as complete as that 
seen over control cells Fig. 2 a]). Background lysis in non- 
Pepper et al.  Urokinase in Migrating Endothelial  Cells  2537 Figure 6. Inhibition of cell division does not prevent caseinolysis. 
Monolayers were treated with mitomycin C (10 gg/ml) for 4 h before 
wounding, and then incubated in the absence of the drug for 24 h 
thereafter,  until  being overlaid. (a) Phase-contrast and (b) dark- 
field views of the wound edge,  indicating the presence of wound 
edge-associated lysis in treated cultures. Photographed after 90 min 
at 37~  Bar, 500 ~tm. 
Figures 4 and 5.  (Fig. 4)  Cycloheximide  inhibits  induction  of 
wound-associated caseinolysis. Cultures  were treated with cyclo- 
heximide (0.1 }.tg/ml)  for 30 min before and for 24 h after wounding. 
(a) The wound edge seen under phase-contrast illumination.  (b) 
Dark-field illumination of the same region showing complete ab- 
sence ofcaseinolysis. Overlays photographed after 120 min at 37~ 
Bar, 500 ~tm. (Fig. 5) Reversibility of  cyclobeximide inhibition. (a) 
Cells incubated continuously in the presence of cycloheximide (0.1 
v,g/ml) for 30 min before wounding and until  overlaid, i.e., 24 h 
after wounding.  Note the complete absence of caseinolysis; posi- 
wounded regions of the mitomycin C-treated monolayer was 
increased  above that  observed  in  nontreated  cultures  (not 
shown);  this is consistent with the report that PA synthesis 
is induced by exposure to mitomycin C and other agents that 
cause DNA damage (Miskin  and Reich,  1980). 
Caseinolysis Is Due to Cell-associated uPA 
Since it has been suggested that the invasive phenotypc is as- 
sociated with uPA rather than tPA activity (see Dan~ et al., 
1985,  and references therein),  we considered it important to 
determine  whether  the caseinolysis  observed at the wound 
edge was due to either or both of these enzymes. Anti-cata- 
lytic  antibodies  against  uPA  from  different  species  cross- 
react poorly, and to our knowledge, antibodies to bovine uPA 
are  at  present  unavailable.  However,  it  has  recently  been 
tions of the wound edges are indicated by arrows.  (b) Nontreated 
control overlaid 24 h  after wounding.  (c) Cells incubated  in the 
presence of cycloheximide as in a, and overlaid after a further 48-h 
incubation  in  the  absence  of the  drug  (i.e.,  overlaid  72  h  after 
wounding). Note the presence of caseinolysis, indicating reversibil- 
ity of cycloheximide inhibition.  (d)Nontreated  control  overlaid 
72 h after wounding.  Overlays photographed after 120 min at 37~ 
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No.  of migrating cells 
per mm of wound edge  % Mitotic figures 
Control  320.0  +  13.1'  1.7  +  0.3 
Mitomycin C  201.9 +  11.7"  0 
Control and mitomycin C-treated  monolayers were wounded with a blade to 
mark the original wound edge,  and 24 h later were fixed and stained by the 
Feulgen  technique.  Photographic  fields measuring  640  gm  x  430  gm, in 
which the wound edge was perpendicular to the long axis of the fields (see Fig. 
7), were randomly selected from both control and treated monolayers. A total 
of 24  fields representing  four fields from each  of three  petri  dishes  in two 
separate experiments were counted from both mitomycin C-treated  and non- 
treated cultures. The total number of cells in the wound and the number  of cells 
in mitosis amongst the migrating cells (as judged  by the presence of stained 
condensed  chromosomes)  were determined  for each  field. The number of 
migrating cells is expressed per millimeter of wound edge, and the number of 
mitotic figures as a percentage of total migrating cells.  Results represent the 
mean  5:  standard error of the mean (* P ,~ 0.001). 
Figure 7. Mitomycin  C inhibits mitosis at the wound edge. Wounded 
monolayers with  or without  preincubation  in  mitomycin C  (lO 
ttg/ml for 4 h before wounding) were fixed and stained by the Feul- 
gen technique 24 h after wounding. (a) Control culture; several mi- 
totic figures (circled) are visible amongst migrating cells. (b) Mito- 
mycin C-treeted culture;  note the  complete absence of mitotic 
figures amongst migrating cells. The original wound edge is indi- 
cated by the dark line on the left. Bar, 200 gm. 
did not inhibit wound-edge caseinolysis in fixed (Fig. 9 b) 
or nonfixed cultures (not shown). We thus conclude that the 
plasminogen-dependent caseinolysis observed in association 
with migrating endothelial cells at the wound edge is due to 
cell-associated uPA activity. 
Discussion 
Production of proteases, and in particular of PAs, has been 
implicated in cell migration in a variety of  invasive biological 
processes. It has been proposed that the two different PAs, 
uPA and tPA, may have different biological functions, uPA 
being primarily involved in invasive processes and tPA exert- 
ing its effect primarily in the circulatory system (see Danr 
et al.,  1985, and references therein). Although most of the 
evidence linking uPA activity to cellular invasion has to date 
been indirect, two reports have demonstrated an inhibition 
of cell invasiveness in the presence of  antibodies to uPA (Os- 
sowski and Reich, 1983; Mignatti et al., 1986). By wounding 
reported that the drug amiloride competitively inhibits the 
catalytic activity of uPA from a variety of species (Vassalli 
and Belin, 1987), without affecting the activity of tPA or of 
plasmin. To determine whether amiloride selectively inhibits 
bovine uPA, the drug was incorporated into a zymographic 
underlay which separates PAs on the basis of their molecular 
weight. Using this technique, we have found that amiloride 
inhibits the catalytic activity of Mr 47,000 bovine uPA,  with- 
out affecting that of the Mr 72,000 bovine tPA (Fig.  8 a). 
For the specific inhibition of tPA activity, we have taken 
advantage of the excellent cross-species reactivity of anti- 
catalytic anti-tPA antibodies. Fig. 8 b demonstrates that Mr 
72,000 bovine tPA and the Mr  100,000 tPA-inhibitor com- 
plex (Loskutoff  et al., 1986) are inhibited by affinity-purified 
anti-human tPA antibodies. 
Using our wounded monolayer model, we explored the 
effect of amiloride and anti-catalytic anti-tPA antibodies on 
wound-associated caseinolysis. Experiments were performed 
on fixed cells to avoid the possible effects of amiloride related 
to  inhibition  of the  Na§  + antiport  system  (Seifter and 
Aronson,  1986).  Amiloride  incorporated into  the overlay 
completely inhibited caseinolysis along the wound edge (Fig. 
9 a). In contrast, affinity-purified anti-human tPA antibodies 
Figure 8.  Zymographic assay. (a) Samples of conditioned media 
(Media) and cells (Cells) from PMA-treated BME cells were sepa- 
rated by SDS-PAGE  and subjected to zymography with (+) or with- 
out (-) incorporation of amiloride into the underlay. (b) Samples 
of conditioned media from PMA-treated BME or HeLa cells were 
prepared as above with (+) or without (-) the incorporation of 
anti-tPA antibodies into the underlay. See text for details. (HeLa 
cell supernatant was used as a source of human tPA.) 
Pepper et al.  Urokinase  in Migrating  Endothelial Cells  2539 Figure 9. Wound  edge cells produce urokinase. Cultures were fixed 
24 h after wounding, and overlaid in the presence of plasminogen 
and either amiloride (a) or anti-tPA antibodies (b). (c) Control. 
Overlays photographed after 60 min at 3"/~ 
a confluent monolayer of endothelial cells and overlaying the 
monolayer with a casein-agar mixture containing plasmino- 
gen, we demonstrate here that there is an increase in uPA ac- 
tivity specifically associated with cells migrating from the 
edge of the wound, and that this activity ceases when the 
wound has closed. To our knowledge, this is the first direct 
demonstration of an increase in uPA activity in cells that are 
in the process of migration, uPA immunoreactivity has re- 
cently been localized to the leading edge of migrating ker- 
atinocytes (Morioka et al.,  1987). 
It has been demonstrated that endothelial cells produce 
both uPA and tPA (Levin and Loskutoff, 1982; Moscatelli, 
1986), and that in bovine capillary endothelial cell cultures 
uPA remains primarily cell-associated whereas tPA is mostly 
secreted  (Moscatelli,  1986). Our experimental system in- 
volves cell fixation for the identification  of the PAs expressed 
by migrating cells, which allows us only to characterize cell- 
associated enzyme(s). We have however observed that anti- 
catalytic anti-tPA antibodies do not inhibit wound edge ca- 
seinolysis in nonfixed cells, thereby providing evidence that 
secreted tPA does not account for the increased catalytic 
activity. The use of amiloride and anti-tPA antibodies there- 
fore demonstrates that wound-associated proteolysis is due 
to increased levels  of uPA  in or on migrating endothelial 
cells. 
The wounded monolayer model has been used to study the 
mechanisms and kinetics of endothelial regeneration, and it 
has been shown that wounding initiates both cell migration 
and division (Sholley et al.,  1977; Selden and  Schwartz, 
1979; Ryan et al.,  1982). Cell-cycle dependent variations in 
PA activity and uPA mRNA levels have been reported (Rohr- 
lich and Rifldn, 1977; Loskutoff  and Paul, 1978; Aggeler et 
al., 1982; Grimaldi et al., 1986; Scott et al., 1987). We have 
found that wounding induces uPA activity both in the pres- 
ence and absence of cell division. However, it has been ob- 
served that a cell-cycle specific increase in uPA mRNA oc- 
curs during G0/GI transition (Grimaldi et al.,  1986). Since 
the antiproliferative effect  of mitomycin  C is thought to result 
from its ability to cross-link complementary DNA strands 
(Iyer and Szybalski, 1963; Tomasz et al.,  1987), treatment 
with this drug may allow ceils to be recruited into G1. Thus, 
although our findings demonstrate that cell division is not re- 
quired for induction of uPA activity, it is conceivable that a 
wound-induced G0/G1 transition might contribute to wound 
edge-associated proteolysis. 
The precise mechanisms responsible for the observed in- 
crease in uPA activity in response to mechanical wounding 
remain to be determined. It has been proposed that signal 
transduction to the nucleus may be accomplished via the 
cytoskeleton  (Bissell et al., 1982). Since wounding is accom- 
panied by a reorganization of the endothelial cell cytoskele- 
ton (Gotlieb et al., 1981, 1983, 1984; Mascardo and Sherline, 
1984; Gabbiani et al.,  1984; Pratt et al.,  1984; Hormia et 
al., 1985; Young and Herman, 1985), the effect we observe 
may result from a cytoskeletally mediated signal to the cell 
nucleus. 
Although it has been proposed that the increase  in PA 
production associated with cellular invasion is necessary for 
the degradation of the basement membrane and extracellular 
matrix components (Mullins and Rohrlich,  1983; Saksela, 
1985;  Dan~ et al.,  1985; Goldfarb and Liotta,  1986),  the 
precise role(s) of PAs in the invasive process remain to be 
established.  Using  the wounded monolayer model,  it has 
been  reported  that  migration of normal  and  transformed 
fibroblasts (Ossowski et al.,  1973, 1975) and smooth muscle 
cells (Schleef and Birdwell, 1982) is dependent on the pres- 
ence of plasminogen. However, this was not the case for bo- 
vine aortic endothelial cells, whose migration was unaffected 
by the removal of plasminogen from the serum (Schleef and 
Birdwell, 1982). The addition of a variety of serine protease 
inhibitors to the medium after wounding also did not affect 
endothelial cell migration (Schleef  and Birdwell, 1982). This 
is in keeping with our previous findings that the addition of 
serine protease  inhibitors or the  removal of plasminogen 
does not affect PMA- or basic fibroblast growth factor-in- 
duced endothelial cell invasion of a three-dimensional colla- 
gen (Montesano and Orci,  1985; and unpublished observa- 
tion) or fibrin (Montesano et al.,  1987) matrix. Therefore, 
although wounding, PMA (Levin and Loskutoff, 1979; Mos- 
catelli et al.,  1980; Gross et al.,  1982; Moscatelli,  1986), 
basic fibroblast growth factor (Montesano et al., 1986; Mos- 
catelli et al.,  1986a,  b), and other angiogenic preparations 
(Gross et al.,  1983) stimulate PA production, there is pres- 
ently no evidence for a causal role of these enzymes in the 
processes of endothelial cell migration or invasion in our 
simplified in vitro systems. Plasminogen activation is, how- 
ever, likely to represent only one member of a cohort of en- 
zymatic and other cellular events required for migratory or 
invasive processes; the absence of a single member, for ex- 
ample, plasminogen activation, need not therefore necessar- 
ily perturb these processes. Furthermore, whether plasmin- 
ogen activation is necessary for endotheli  .al cell migration 
and invasion in the more complex in vivo environment re- 
mains to be established. 
In conclusion, we have devised a novel approach that in- 
volves overlaying a wounded monolayer  of  cells with a casein- 
agar mixture containing plasminogen, to determine whether 
migrating cells display an increase in PA activity. Using this 
model, we have observed an induction of uPA activity in en- 
dothelial cells migrating from the edges of an experimental 
wound, and a reversion of this activity to background levels 
upon cessation of movement, when the wound has closed. 
These results provide strong support for the association be- 
tween migratory behavior and increased expression of uPA 
activity. 
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